Physician profile
Michael Plastini
NPI 1346630431
$6,525.06
in general payments reported to CMS, 2019-2025
16 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.40 · 2021: $1,306 · 2022: $743 · 2023: $3,283 · 2024: $349 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,750 · Food and Beverage: $1,081 · Long Term Medical Supply Or Device Loan: $326 · Travel and Lodging: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,750.00 |
| Food and Beverage | $1,081.22 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Travel and Lodging | $253.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $3,046.26 | 2022-2023 | |
| Allergan, INC. | $810.71 | 2019-2022 | |
| Sientra, INC. | $727.34 | 2021-2022 | |
| Galderma Laboratories, L.P. | $427.40 | 2023-2025 | Dysport |
| Integra Lifesciences Corporation | $406.76 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Mentor Worldwide LLC | $346.81 | 2021-2022 | |
| Tela Bio, INC. | $267.28 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Motiva USA, LLC | $138.47 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $97.98 | 2021 | |
| Merz North America, INC. | $57.79 | 2023 | Xeomin |
| Revance Therapeutics, INC. | $47.93 | 2025 | Daxxify |
| Organogenesis INC. | $46.32 | 2022 | |
| Janssen Biotech, INC. | $42.96 | 2025 | Tremfya |
| Acera Surgical, INC. | $26.47 | 2022 | |
| Ucb, INC. | $18.43 | 2025 | Bimzelx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $16.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Plastini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.